Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:
“It was a great honor and pleasure to participate in the 4th King Hussein Cancer Foundation and Center (KHCC) Research Conference 2026, held on October 15–17 at the Dead Sea, Jordan.
An exceptional conference that brought together leading oncologists, researchers, and healthcare leaders from across the Arab region and beyond, united by a shared commitment to advancing cancer research, clinical trials, and innovation. What impressed me most was the remarkable quality of the scientific discussions, the collaborative spirit, and the clear ambition to strengthen cancer research across our region.
My sincere congratulations to Dr. Asem Mansour, Conference President, Prof. Hikmat Abdel-Razeq, Iyad Sultan and Amal Al Omari and the entire KHCC leadership and organizing team for delivering such an outstanding scientific event.
Special appreciation to HRH Princess Ghida Talal for her continued visionary leadership and unwavering commitment to advancing cancer care and research.
I strongly believe that the future of cancer research in the Arab world depends on collaboration, regional partnerships, and our collective ability to translate scientific discoveries into better outcomes for our patients.Proud to have been part of this exceptional gathering and looking forward to further collaborations.”
You can also read: King Hussein Cancer Center Launches Survey to Strengthen Collaborative Oncology Research in the Arab World
